Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Kruse-Jarres

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Hematology. American Society of Hematology. Education Program|December 6, 2015
Acquired bleeding disorders in the elderlyRebecca Kruse-Jarres
Hematology. American Society of Hematology. Education Program|December 14, 2011
Current controversies in the formation and treatment of alloantibodies to factor VIII in congenital hemophilia ARebecca Kruse-Jarres
Hematology. American Society of Hematology. Education Program|December 9, 2023
The role of emicizumab in acquired hemophilia AJacqueline Poston, Rebecca Kruse-Jarres
Blood Reviews|October 8, 2013
Management of sickle cell disease from childhood through adulthoodJulie Kanter, Rebecca Kruse-Jarres
Transfusion Medicine Reviews|October 24, 2022
Advances in Acquired Hemophilia AJacqueline N Poston, Rebecca Kruse-Jarres
Blood|January 31, 2018
How I treat type 2B von Willebrand diseaseRebecca Kruse-Jarres, Jill M Johnsen
Blood|April 9, 2016
A new era for hemophilia B treatmentJason A Taylor, Rebecca Kruse-Jarres
Blood|September 6, 2023
How I treat von Willebrand disorders in older adultsJacqueline N Poston, Rebecca Kruse-Jarres
The Journal of Emergency Medicine|September 2, 2008
Emergency department care for patients with hemophilia and von Willebrand diseaseTammuella Singleton, Rebecca Kruse-Jarres, Cindy Leissinger
Expert Opinion on Biological Therapy|November 8, 2008
Immune tolerance induction for the eradication of inhibitors in patients with hemophilia ARebecca Kruse-Jarres, Brian Barnett, Cindy Leissinger
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Hematology. American Society of Hematology. Education Program|December 6, 2015
Acquired bleeding disorders in the elderlyRebecca Kruse-Jarres
Hematology. American Society of Hematology. Education Program|December 14, 2011
Current controversies in the formation and treatment of alloantibodies to factor VIII in congenital hemophilia ARebecca Kruse-Jarres
Hematology. American Society of Hematology. Education Program|December 9, 2023
The role of emicizumab in acquired hemophilia AJacqueline Poston, Rebecca Kruse-Jarres
Blood Reviews|October 8, 2013
Management of sickle cell disease from childhood through adulthoodJulie Kanter, Rebecca Kruse-Jarres
Transfusion Medicine Reviews|October 24, 2022
Advances in Acquired Hemophilia AJacqueline N Poston, Rebecca Kruse-Jarres
Blood|January 31, 2018
How I treat type 2B von Willebrand diseaseRebecca Kruse-Jarres, Jill M Johnsen
Blood|April 9, 2016
A new era for hemophilia B treatmentJason A Taylor, Rebecca Kruse-Jarres
Blood|September 6, 2023
How I treat von Willebrand disorders in older adultsJacqueline N Poston, Rebecca Kruse-Jarres
The Journal of Emergency Medicine|September 2, 2008
Emergency department care for patients with hemophilia and von Willebrand diseaseTammuella Singleton, Rebecca Kruse-Jarres, Cindy Leissinger
Expert Opinion on Biological Therapy|November 8, 2008
Immune tolerance induction for the eradication of inhibitors in patients with hemophilia ARebecca Kruse-Jarres, Brian Barnett, Cindy Leissinger
Pageof 6